» Articles » PMID: 31500658

Cancer-associated Adipocytes: Key Players in Breast Cancer Progression

Overview
Journal J Hematol Oncol
Publisher Biomed Central
Specialties Hematology
Oncology
Date 2019 Sep 11
PMID 31500658
Citations 228
Authors
Affiliations
Soon will be listed here.
Abstract

Adipocytes are one of the primary stromal cells in many tissues, and they are considered to play an active role in the tumor microenvironment. Cancer-associated adipocytes (CAAs) are not only found adjacent to cancer cells, but also communicate with cancer cells through releasing various factors that can mediate local and systemic effects. The adipocyte-cancer cell crosstalk leads to phenotypical and functional changes of both cell types, which can further enhance tumor progression. Indeed, obesity, which is associated with an increase in adipose mass and an alteration of adipose tissue, is becoming pandemic in some countries and it is now considered to be an independent risk factor for cancer progression. In this review, we focus on the potential mechanisms involved with special attention to the adipocyte-cancer cell circle in breast cancer. We envisage that besides having a direct impact on tumor cells, CAAs systemically preconditions the tumor microenvironment by favoring anti-tumor immunity. A better understanding of cancer-associated adipocytes and the key molecular events in the adipocyte-cancer cell crosstalk will provide insights into tumor biology and permit the optimization of therapeutic strategies.

Citing Articles

Nutrients Lowering Obesity-Linked Chemokines Blamable for Metastasis.

Ion G, Bostan M, Hardman W, Putt McFarland M, Bleotu C, Radu N Int J Mol Sci. 2025; 26(5).

PMID: 40076892 PMC: 11899810. DOI: 10.3390/ijms26052275.


NFIX suppresses breast cancer cell proliferation by delaying mitosis through downregulation of CDK1 expression.

Ma H, Sun R, Tian T, Zhou X, Chen Z, Cao X Cell Death Discov. 2025; 11(1):77.

PMID: 40000619 PMC: 11861311. DOI: 10.1038/s41420-025-02361-8.


Comprehensive analysis of lipid metabolic signatures identified CEBPD promotes breast cancer cell proliferation.

Zhao Y, He H, Huang L, Yu L Sci Rep. 2025; 15(1):6570.

PMID: 39994306 PMC: 11850814. DOI: 10.1038/s41598-025-90869-5.


Periprostatic Adipose Tissue as a Contributor to Prostate Cancer Pathogenesis: A Narrative Review.

Drewa J, Lazar-Juszczak K, Adamowicz J, Juszczak K Cancers (Basel). 2025; 17(3).

PMID: 39941741 PMC: 11816168. DOI: 10.3390/cancers17030372.


Tumor microenvironment targeted nano-drug delivery systems for multidrug resistant tumor therapy.

Shao X, Zhao X, Wang B, Fan J, Wang J, An H Theranostics. 2025; 15(5):1689-1714.

PMID: 39897552 PMC: 11780529. DOI: 10.7150/thno.103636.


References
1.
Present D, Rutgeerts P, Targan S, Hanauer S, Mayer L, van Hogezand R . Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med. 1999; 340(18):1398-405. DOI: 10.1056/NEJM199905063401804. View

2.
Ueno T, Toi M, Saji H, Muta M, Bando H, Kuroi K . Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res. 2000; 6(8):3282-9. View

3.
Saji H, Koike M, Yamori T, Saji S, Seiki M, Matsushima K . Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma. Cancer. 2001; 92(5):1085-91. DOI: 10.1002/1097-0142(20010901)92:5<1085::aid-cncr1424>3.0.co;2-k. View

4.
Chan G, Deckelbaum R, Bolivar I, Goltzman D, Karaplis A . PTHrP inhibits adipocyte differentiation by down-regulating PPAR gamma activity via a MAPK-dependent pathway. Endocrinology. 2001; 142(11):4900-9. DOI: 10.1210/endo.142.11.8515. View

5.
Blumenauer B, Judd M, Wells G, Burls A, Cranney A, Hochberg M . Infliximab for the treatment of rheumatoid arthritis. Cochrane Database Syst Rev. 2002; (3):CD003785. PMC: 8729322. DOI: 10.1002/14651858.CD003785. View